Ceragenix Pharmaceuticals
 | This article includes a improve this article by introducing more precise citations. (October 2014) ) |
Ceragenix Pharmaceuticals, Inc. is a
gram negative bacteria
, these agents are being developed as anti-infective medical device coatings and as therapeutics for antibiotic-resistant organisms.
Products
Ceragenix developed
eczema).[2]
Ceragenix's second platform technology addresses
eukaryotic cells
.
References
- ^ "Ceragenix Pharmaceuticals Inc". Bloomberg L.P. June 16, 2020.
- ^ "Ceragenix Pharmaceuticals, Inc. and BexPharm Enter Into Distribution and Supply Agreement for EpiCeram(R)". BioSpace. February 22, 2010.
External links
- Innovations & Ideas." Denver Post. (subscription required)
- Ceragenix Pharmaceuticals Gets Frost & Sullivan Product Innovation Award for Cerashield Coating – Wireless News | HighBeam Research
- CERAGENIX PHARMACEUTICALS SHOWS NET LOSS FOR 3rd QUARTER – US Fed News Service, Including US State News | HighBeam Research